Drug-Induced Pancreatitis - L-Asparaginase

Drug-induced pancreatitis is inflammation of the pancreas caused by certain medications. L-asparaginase is a chemotherapy drug used to treat acute lymphoblastic leukemia, especially in children. This medication causes pancreatitis in 2 to 16 out of every 100 patients who receive it.

The pancreas is an organ behind your stomach that makes digestive enzymes and hormones like insulin. L-asparaginase works by breaking down an amino acid called asparagine that cancer cells need to grow. Unfortunately, this process also decreases protein production throughout the body and can damage pancreas cells directly. When pancreas cells become inflamed or damaged, they release enzymes like lipase into the bloodstream at higher levels than normal.

This type of pancreatitis usually develops during active treatment with L-asparaginase. It can range from mild discomfort to severe inflammation requiring hospitalization. The condition often resolves after stopping the medication, but monitoring is essential during treatment to catch problems early.

• Sudden severe pain in the upper abdomen that may spread to the back
• Nausea and vomiting that does not improve
• Fever above 100.4 degrees Fahrenheit
• Rapid heart rate or rapid breathing
• Swollen or tender abdomen
• Loss of appetite and inability to eat
• Abdominal pain that worsens after eating
• Yellowing of skin or eyes in severe cases

Some patients may have mild symptoms initially that worsen over hours or days. Early detection through blood testing can identify pancreatitis before symptoms become severe. Children receiving L-asparaginase may have trouble describing their pain, so careful monitoring is important.

L-asparaginase causes pancreatitis through two main mechanisms. First, it breaks down asparagine and glutamine amino acids throughout the body, which reduces the pancreas's ability to make the proteins it needs to function properly. Second, the drug appears to have direct toxic effects on pancreatic cells themselves. These combined effects trigger inflammation that can range from mild to life-threatening.

Risk factors for developing L-asparaginase pancreatitis include younger age, higher cumulative doses of the medication, and certain genetic factors. Patients who have had pancreatitis from other causes may be at higher risk. The type of L-asparaginase used matters too, with some formulations causing pancreatitis more often than others. Combining L-asparaginase with corticosteroids like prednisone or dexamethasone may also increase risk.

Doctors diagnose drug-induced pancreatitis by measuring pancreatic enzymes in the blood and evaluating symptoms. Lipase is the most sensitive blood test for detecting pancreas inflammation. A lipase level more than three times the upper limit of normal, combined with abdominal pain, strongly suggests pancreatitis. Blood tests also check for complications like high blood sugar, low calcium, and kidney problems.

Imaging tests like CT scans or ultrasounds help doctors see inflammation and rule out other causes of abdominal pain. For patients receiving L-asparaginase, regular lipase monitoring during treatment can catch pancreatitis early, even before symptoms appear. Rite Aid offers lipase testing as an add-on to help patients and their healthcare teams monitor pancreas health during chemotherapy. Early detection allows for faster treatment adjustments and better outcomes.

• Stop L-asparaginase immediately when pancreatitis is confirmed
• Hospitalization for intravenous fluids and pain management
• Nothing by mouth for several days to rest the pancreas
• Pain medications to manage severe abdominal discomfort
• Nutritional support through IV fluids or feeding tubes if needed
• Monitor blood tests daily to track enzyme levels and complications
• Gradual reintroduction of clear liquids then solid foods as inflammation resolves
• Switch to alternative chemotherapy drugs that do not contain L-asparaginase
• Long-term follow-up to check for chronic pancreas damage or diabetes